SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 15-12B - Securities registration termination [Section 12(b)]:
SEC Accession No. 0001104659-21-146860
Filing Date
2021-12-06
Accepted
2021-12-06 17:25:20
Documents
1
Effectiveness Date
2021-12-06

Document Format Files

Seq Description Document Type Size
1 15-12B tm2134718d1_1512b.htm 15-12B 11095
  Complete submission text file 0001104659-21-146860.txt   12199
Mailing Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 15-12B | Act: 34 | File No.: 001-36399 | Film No.: 211473980
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences